Investment Centers of America’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-82,897
Closed -$5.03M 307
2017
Q3
$5.03M Buy
82,897
+2,580
+3% +$156K 0.37% 65
2017
Q2
$4.88M Buy
80,317
+6,722
+9% +$409K 0.37% 69
2017
Q1
$4.45M Sell
73,595
-19,296
-21% -$1.17M 0.34% 76
2016
Q4
$5.24M Buy
92,891
+8,946
+11% +$524K 0.45% 58
2016
Q3
$4.97M Buy
83,945
+1,431
+2% +$83.7K 0.51% 50
2016
Q2
$4.56M Sell
82,514
-4,618
-5% -$246K 0.51% 53
2016
Q1
$4.39M Buy
87,132
+5,812
+7% +$285K 0.49% 54
2015
Q4
$4.09M Buy
81,320
+1,570
+2% +$79.2K 0.53% 49
2015
Q3
$3.76M Buy
79,750
+4,939
+7% +$262K 0.57% 43
2015
Q2
$4.07M Buy
74,811
+10,684
+17% +$599K 0.62% 37
2015
Q1
$3.51M Buy
64,127
+7,514
+13% +$425K 0.52% 48
2014
Q4
$3.07M Buy
56,613
+1,337
+2% +$74.5K 0.66% 32
2014
Q3
$3.14M Buy
55,276
+7,027
+15% +$395K 0.56% 45
2014
Q2
$2.67M Sell
48,249
-8,462
-15% -$462K 0.61% 40
2014
Q1
$2.6M Buy
56,711
+23,030
+68% +$1.19M 0.54% 50
2013
Q4
$1.54M Sell
33,681
-23,030
-41% -$1.05M 0.73% 34
2013
Q3
$2.6M Buy
56,711
+13,640
+32% +$623K 0.53% 51
2013
Q2
$1.91M Buy
+43,071
New +$1.92M 0.52% 57

Other funds holding MRK

Investment Centers of America's MRK Position: Q4 2017 in Review

Investment Centers of America sold out of Merck (MRK) in Q4 2017, closing a stake of 82,897 shares — an estimated $5.03M sold.

Investment Centers of America first reported a position in MRK in Q2 2013 and held it in 18 quarters. The position peaked at $5.24M in Q4 2016. 2,009 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Investment Centers of America reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 82,897 Merck shares in Q4 2017, an estimated $5.03M.
  • Investment Centers of America first reported a position in Merck in Q2 2013 and held it in 18 quarters.
  • Investment Centers of America's Merck position peaked at $5.24M in Q4 2016.
  • 2,009 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.